• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Dana-Farber CEO Emeritus receives ASH Award for Leadership in Promoting Diversity

Bioengineer by Bioengineer
June 23, 2020
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Dana-Farber Cancer Institute

Edward J. Benz, Jr., MD, President and CEO Emeritus of the Dana-Farber Cancer Institute and the Richard and Susan Smith Distinguished Professor at Harvard Medical School, has received the 2020 ASH Award for Leadership in Promoting Diversity.

The Award honors hematologists who have supported the development of an inclusive hematology workforce, encouraged the career development of underrepresented minority trainees, or made a commitment to inclusiveness through contributions in support of ASH’s mission.

An internationally recognized hematologist and physician scientist, Benz has devoted himself to improving workforce diversity in academic medicine and health care. Over the course of his career, he personally trained more than 50 scientists in his own laboratory, a significant proportion of whom were women.

“We are rapidly becoming a pluralistic minority-majority society, all of whose members are susceptible to the broad array of conditions that we as hematologists attempt to decipher, diagnose, and treat. As in all areas of medicine, hematologists need to represent that diversity within our ranks if we are to understand and address the needs and challenges of the patients for whom we provide care… If we do not diversify our ‘person-force’ we will fail to tap into all of the pools of talent needed to make the best use of the tremendous opportunities to apply science to meaningful and equitably shared progress against hematologic illnesses,” Benz commented.

Benz successfully established a culture at Dana-Farber that focused on supporting junior faculty, with specific attention to increasing the number of women and underrepresented minority faculty members. While serving as Director of the Dana-Farber/Harvard Cancer Center, he launched a trans-institutional Initiative to Eliminate Cancer Disparities, designed to coordinate cancer disparities research, enhance minority medical student training, and promote development of a diverse faculty throughout the Harvard cancer enterprise.

Benz also spearheaded a novel partnership with the University of Massachusetts Boston, the area’s largest academic institution that primarily serves minority populations, to develop a more diverse workforce, built upon community partnerships to encourage students from underrepresented backgrounds to pursue careers in health and science. Additionally, he established the first Dana-Farber clinic in a community health center for minority patients.

Benz is currently the principal investigator of a National Institutes of Health R25 grant devoted to promoting minority careers in STEM fields.

The award will be presented during the 62nd ASH Annual Meeting, December 5-8, 2020.

###

Media Contact
Claire Monaghan
[email protected]

Tags: cancerHematologyMedicine/HealthOrganizationResearchers/Scientists/Awards
Share12Tweet8Share2ShareShareShare2

Related Posts

MARCO Drives Myeloid Suppressor Cell Differentiation, Immunity

MARCO Drives Myeloid Suppressor Cell Differentiation, Immunity

August 2, 2025
Personalized ML Wearable Enhances Impaired Arm Function

Personalized ML Wearable Enhances Impaired Arm Function

August 2, 2025

Cancer Cells Trigger Protumor Macrophages via oxLDL

August 2, 2025

RBM17 Drives Liver Cancer via Lipid, Immunity Changes

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    36 shares
    Share 14 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

MARCO Drives Myeloid Suppressor Cell Differentiation, Immunity

CK2–PRC2 Signal Drives Plant Cold Memory Epigenetics

Personalized ML Wearable Enhances Impaired Arm Function

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.